GlassScriptPhysician profile
Deborah P Consoli
NPI 1316980857
$504.87
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $311 · 2020: $70.49 · 2021: $19.75 · 2023: $52.28 · 2024: $51.43.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $104.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $103.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $159.01 | 2019-2024 | |
| Coopersurgical, INC. | $85.29 | 2019-2024 | Paragard T 380a, Paragard T 380a |
| Abbvie INC. | $59.28 | 2019-2023 | Orilissa, Lo Loestrin Fe |
| Amag Pharmaceuticals, INC. | $43.06 | 2019 | |
| Hologic Sales and Service, LLC | $40.32 | 2020 | |
| Roche Diagnostics Corporation | $29.40 | 2019 | |
| Duchesnay USA Incorporated | $22.37 | 2019 | |
| Amgen INC. | $15.52 | 2019 | |
| Covidien LP | $15.07 | 2020 | |
| Astellas Pharma US INC | $12.99 | 2019 | |
| Avion Pharmaceuticals | $11.33 | 2019 | |
| Exeltis, USA INC. | $11.23 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deborah Consoli listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.